Litcius/Paper detail

Optimization of 17α-methyltestosterone dose to produce quality mono-sex Nile tilapia Oreochromis niloticus

Baadruzzoha Sarker, Bipresh Das, Shawon Chakraborty, Mohammad Amzad Hossain, M. M. Mahbub Alam, Sohel Mian, Mohammed Mahbub Iqbal

2022Heliyon19 citationsDOIOpen Access PDF

Abstract

accurately. The highest male 94.44% was obtained at 60 mg 17α-MT/kg feed dose followed by 91.67%, 88.89%, 86.11%, and 47.22% at 70, 80, 50, and 0 mg 17α-MT/kg feed dose. The groups treated with 17α-methyltestosterone hormone showed superior growth performance in comparison to the control group. The highest weight (14.62 ± 0.59 g) and length (92.18 ± 3.01 mm) were found at 60 mg dose whereas the lowest weight (8.64 ± 0.38 g) and length (70.17 ± 3.75 mm) were in the control group. The group given 60 mg 17α-MT feed represented the highest survival rate (84.10%) among other hormone-treated groups. The study disclosed that 60 mg 17α-MT/kg feed might be treated as the optimal dose for producing quality mono-sex male tilapia in the commercial hatchery.

Topics & Concepts

Nile tilapiaOreochromisMethyltestosteroneAnimal scienceTilapiaBiologyInternal medicineFisheryEndocrinologyFish <Actinopterygii>MedicineReproductive biology and impacts on aquatic speciesAquaculture Nutrition and GrowthGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Optimization of 17α-methyltestosterone dose to produce quality mono-sex Nile tilapia Oreochromis niloticus | Litcius